GATA2 decommissioning of enhancers: A mechanism to constrain inflammatory signaling
Open Access
- 25 September 2025
- journal article
- Published by Elsevier in Cell Reports
- Vol. 44 (10) , 116344
Abstract
No abstract availableKeywords
Funding Information
- National Heart, Lung, and Blood Institute (T32 HL07899)
- National Institute of Diabetes and Digestive and Kidney Diseases (F31 DK138794-01A1)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK68634)
- National Institutes of Health
- National Cancer Institute
This publication has 84 references indexed in Scilit:
- Forged in the fire: Lasting impacts of inflammation on hematopoietic progenitorsExperimental Hematology, 2024
- Pleiotropy and Specificity: Insights from the Interleukin 6 Family of CytokinesImmunity, 2019
- Germline GATA2 Mutation and Bone Marrow FailureHematology/Oncology Clinics of North America, 2018
- Genomic Characterization of Murine Monocytes Reveals C/EBPβ Transcription Factor Dependence of Ly6C − CellsImmunity, 2017
- Asymmetric Action of STAT Transcription Factors Drives Transcriptional Outputs and Cytokine SpecificityImmunity, 2015
- IL-6 Controls Leukemic Multipotent Progenitor Cell Fate and Contributes to Chronic Myelogenous Leukemia DevelopmentCancer Cell, 2011
- Dynamic Exchange at Regulatory Elements during Chromatin Remodeling Underlies Assisted Loading MechanismCell, 2011
- Identification and Characterization of Enhancers Controlling the Inflammatory Gene Expression Program in MacrophagesImmunity, 2010
- Functional and biochemical association of Hck with the LIF/IL‐6 receptor signal transducing subunit gp130 in embryonic stem cells.The EMBO Journal, 1994
- The erythroid-specific transcription factor eryf1: A new finger proteinCell, 1989